Volitionrx (VNRX.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Event Tracking

Dec11

VolitionRx Ltd. Releases Capture-Seq Liquid Biopsy Method

14:01

Nov13

Volitionrx released FY2025 Q3 earnings on November 13 Pre-Market EST, actual revenue USD 627.28 K (forecast USD 715.59 K), actual EPS USD -0.0499 (forecast USD -0.0442)

14:30

Volitionrx released FY2025 9 Months earnings on November 13 Pre-Market (EST), actual revenue USD 1.28 M, actual EPS USD -0.1671

14:30

Nov10

VolitionRx Limited to Release Third Quarter 2025 Financial Results

13:45

Nov7

Volitionrx to Release FY2025 Q3 Earnings on November 14 Pre-Market EST, Forecast Revenue USD 715.59 K, EPS USD -0.0442

00:06

Oct2

VolitionRX Ltd. Sponsors GenomeWeb Webinar to Showcase Nu.Q® Discover Service

12:45

Schedules & Filings

Schedules

Filings

Nov13

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 627.28 K, Net Income -5.378 M, EPS -0.0497

Aug14

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 406.69 K, Net Income -6.284 M, EPS -0.0612

May15

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 246.39 K, Net Income -5.424 M, EPS -0.0561

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change